Sort by
Refine Your Search
-
to start a PhD trajectory in liquid biopsy method development for improved cancer detection. The project has a strong focus on novel design and implementation of different IT tools and coordination of team
-
clinical potential of altered lipid metabolism in prostate cancer (PCa). Applicants can choose from 9 interconnected PhD projects, along the research pipeline. DC1-3 will generate a comprehensive and spatial
-
biopsies in colorectal cancer Position You will perform research in the field of liquid biopsies, with a focus on colorectal cancer. The objective of this project is to evaluate the reliability of DNA
-
clinical potential of altered lipid metabolism in prostate cancer (PCa). Through its modular and bidirectional nature with multiple entry points, this pipeline is expected to generate outputs at multiple
-
tool based on biological and radiological MRI imaging features. The aim is to develop a stratification tool that can be implemented later on in the clinical radiotherapy workflow of head and neck cancer
-
scholarship holder to study the epigenetic landscapes of histopathological growth patterns in colorectal cancer liver metastasis. Position This PhD scholarship clinical research allows young researchers
-
qualitative and quantitative information from electrochemical data. These data models will improve the state-of-the-art in (bio)electrochemical sensing, to make an impact in e.g. cancer diagnosis, on-site
-
from membrane permeability calculations, for instance by reducing memory in the simulations. Developing new methods for screening of the binding kinetics of candidate cancer drugs to protein binding
-
an impact in e.g. cancer diagnosis, on-site illicit drug sensing and infectious disease diagnostics. It is crucial that the information extracted from the electrochemical data is maximized to achieve high
-
, viral and non-viral vectors will be used to develop innovative personalised therapeutic solutions, enabling researchers to tackle serious hereditary and chronic diseases and cancers by validating a